# A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

> **NCT00511563** · PHASE2 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** GW876008 and GSK561679

## Key facts

- **NCT ID:** NCT00511563
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-08
- **Primary completion:** 2012-11
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancelled before active due to the results of emerging scientific data
- **Last updated:** 2015-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511563, "A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT00511563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*